|
⚲
|
| Keyboard |
| Pedersen Anders
✚
|
|
|---|---|
| CIK # | 0001825779 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001825779] | |
| 4 | [0001825779] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Pedersen Anders | |
| Damora Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2023-01-04 | Grant | 115,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2022-01-04 | Grant | 118,750 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2021-01-05 | Grant | 100,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Series C-1 Preferred Stock · derivative
|
2020-11-02 | Conversion | 1,441 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2020-11-02 | Conversion | 3,746 | ||
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2020-10-07 | Grant | 77,991 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2020-06-24 | Grant | 142,983 | $0.00 |